Other

Pfizer Corporation

Kenneth Owen Richardson

Arthur Michael Kassel

Stephen J Ray

Timothy H Cronin

Kelvin Cooper

John Steele

Michael J Fray

Peter J Whittle

A subsurface emitter includes a piston valve both preventing water from draining from the system, and blocking the entry of roots and soil into the emitter body. A nozzle is present at one or both ends of a vertical tube. A piston is held in a normally closed position by a spring in the absence of water pressure, covering ports in the nozzle. When sufficient water pressure in provided, the spring is compressed and the nozzle uncovers the port providing a subsurface spray of water. The spray of water is sufficient to clear mineral deposits which otherwise may accumulate and block the port.

Subsurface irrigation

A subsurface emitter includes a valve both preventing water from draining from the system and blocking the entry of roots and soil into the emitter body. A nozzle is present at one or both ends of a vertical tube. A piston is held in a normally closed position by a spring in the absence of water pressure, covering at least one port in the nozzle. When sufficient water pressure in provided, the spring is compressed and the nozzle uncovers the port providing a subsurface spray of water. The spray of water is sufficient to clear mineral deposits which otherwise may accumulate and block the port.

The present invention relates to a gripping device that removably attaches onto a user's wrist to enable the user to grip onto a handle. The gripping device comprises a wrist-wrapping, elongated belt portion having opposite ends, and a gripping structure that extends outward from the plane of the belt portion.

Gripping device

The present invention is a massage device () for massaging one or more body parts. The device includes a first paddle () extending outward from the side of a housing () that is rotatably mounted on a wobble bearing journal () of a wobble bearing (); a drive shaft () from a rotational motive device () that is rotationally engaged with a passage () of the journal (), wherein the passage () passes through the journal () at a non-zero wobble angle (&#x3b8;) measured between a rotational axis (RA) of the drive shaft () and the geometric axis of revolution (CS) of the journal (); a detaining fin () attached to the housing () and encompassing a detaining rod (); and a frame () that fixedly holds the detaining rod () and rotational holds the drive shaft ().

Massage device

According to the invention, there is disclosed a leg stretching devicecharacterized by a leg support armmounted to a primary shaftat a first end, the leg support arm having a leg supportsecured to the leg support arm at a second end; and structure for rotating the primary shaft from an initial position to a final position so that the leg support arm moves through a range of about 30 to 70 degrees and preferably about 40 to 60 degrees. In addition, there are provided structure for adjusting the location of the initial position of the leg support arm. In addition, the length of leg support armis adjustable.

Leg stretching machine

An exercising device is described that permits exercising the arms and/or legs of a person, such as a wheelchair-bound person. The device has a drive shaft to which foot pedals are mounted. The foot pedals are mounted off of the axis of rotation and at an angle to the axis of rotation such that when a person's feet are strapped to the foot pedals and the drive shaft is rotated, the feet will circle the axis of rotation and will cause circular motion of the ankles. Arm exercising members are attached to the drive shaft will cause an oscillatory pivotal motion of the arm exercising members.

Exercising device

The invention provides antifungal compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, whereinR is phenyl substituted by 1 to 3 substituents each independently selected from halo, --CF.sub.3 and --OCF.sub.3 ;

Triazole antifungal agents

The invention provide antifungal compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, wherein R is phenyl substituted by 1 to 3 substituents each independently selected from halo, --CF.sub.3 and --OCF.sub.3 ;

Platelet activating factor antagonists of formula (I): ##STR1## wherein R is phenyl or phenyl substituted by one or more substituents selected from nitro, halo, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, aryl(C.sub.1 -C.sub.4)alkoxy, fluoro(C.sub.1 -C.sub.4)alkoxy, C.sub.1 -C.sub.4 alkylthio, C.sub.1 -C.sub.4 alkylsulphonyl, hydroxy, trifluoromethyl and cyano, or is phenyl fused to a dioxole ring;

1,4-dihydro-2-(4-[benzimidazol-l-yl]phenyl)-pyridines as platelet

Antifungal 1-[3-(substituted)-2-hydroxy-2-(perfluoroalkyl)-propyl]triazole derivatives wherein the 3-propyl substituent represents optionally substituted phenoxy, heteroaryloxy, alkylthio, alkylsulfinyl, alkylsulfonyl or optionally substituted carbamoyl.

Novel alkyl esters of quinoxaline-di-N-oxide-2-carboxylic acid substituted on the alkyl portion of the ester by hydroxy, acyloxy, N-alkyl carbamyloxy, dialkylaminoacyloxy, carboxyacyloxy, alkoxycarbonyloxy, haloacyloxy, amino and mono- and disubstituted amino, useful as antibacterial agents and in promoting growth and improving feed efficiency of animals in general.

Growing community of inventors

Whittier, CA, United States of America

Kenneth Owen Richardson